|
IPSC | Century Therapeutics, Inc. |
|
|
IPSC | Century Therapeutics, Inc. |
| Biological Products (no Diagnostic Substances) |
| Book value per $ invested | $ 5.95 |
| Leverage | 26.27% |
| Market Cap | $ 35.3m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -22.9m |
| Margin | -19.99% |
None